Level of muscle regeneration in limb-girdle muscular dystrophy type 2I relates to genotype and clinical severity

Skeletal Muscle

Volumn 1, Issue 1, 2011, Pages

  Krag, Thomas O ^a   Hauerslev, Simon ^a   Sveen, Marie L ^a   Schwartz, Malene ^a   Vissing, John ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860346033     PISSN: None     EISSN: 20445040     Source Type: Journal    
DOI: 10.1186/2044-5040-1-31     Document Type: Article

References (40)

1. Brockington M, Yuva Y, Prandini P, Brown SC, Torelli S, Benson MA, Herrmann R, Anderson LV, Bashir R, Burgunder JM, et al. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 2001, 10:2851-2859. 10.1093/hmg/10.25.2851, 11741828.
2. Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA, Ponting CP, Estournet B, Romero NB, Mercuri E, et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet 2001, 69:1198-1209. 10.1086/324412, 1235559, 11592034.
3. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 1992, 20;355:696-702.
4. Esapa CT, McIlhinney RA, Blake DJ. Fukutin-related protein mutations that cause congenital muscular dystrophy result in ER-retention of the mutant protein in cultured cells. Hum Mol Genet 2005, 14:295-305.
5. Torelli S, Brown SC, Brockington M, Dolatshad NF, Jimenez C, Skordis L, Feng LH, Merlini L, Jones DH, Romero N, et al. Sub-cellular localisation of fukutin related protein in different cell lines and in the muscle of patients with MDC1C and LGMD2I. Neuromuscul Disord 2005, 15:836-843. 10.1016/j.nmd.2005.09.004, 16288869.
6. Sveen ML, Schwartz M, Vissing J. High prevalence and phenotype-genotype correlations of limb girdle muscular dystrophy type 2I in Denmark. Ann Neurol 2006, 59:808-815. 10.1002/ana.20824, 16634037.
7. Sveen ML, Schwartz M, Vissing J. High prevalence and phenotype-genotype correlations of limb girdle muscular dystrophy type 2I in Denmark. Ann Neurol 2006, 59:808-815. 10.1002/ana.20824, 16634037.
8. Schwartz M, Hertz JM, Sveen ML, Vissing J. LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype. Neurology 2005, 64:1635-1637. 10.1212/01.WNL.0000157654.59374.E5, 15883334.
9. Brockington M, Yuva Y, Prandini P, Brown SC, Torelli S, Benson MA, Herrmann R, Anderson LV, Bashir R, Burgunder JM, et al. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 2001, 10:2851-2859. 10.1093/hmg/10.25.2851, 11741828.
10. Sveen ML, Schwartz M, Vissing J. High prevalence and phenotype-genotype correlations of limb girdle muscular dystrophy type 2I in Denmark. Ann Neurol 2006, 59:808-815. 10.1002/ana.20824, 16634037.
11. Wroblewski R, Edstrom L, Mair WG. Five different types of centrally nucleated muscle fibres in man: elemental composition and morphological criteria. A study of myopathies, fetal tissue and muscle spindle. J Submicrosc Cytol 1982, 14:377-387.
12. Sartore S, Gorza L, Schiaffino S. Fetal myosin heavy chains in regenerating muscle. Nature 1982, 298:294-296. 10.1038/298294a0, 7045696.
13. Grounds MD, Garrett KL, Lai MC, Wright WE, Beilharz MW. Identification of skeletal muscle precursor cells in vivo by use of MyoD1 and myogenin probes. Cell Tissue Res 1992, 267:99-104. 10.1007/BF00318695, 1310442.
14. Marsh DR, Criswell DS, Carson JA, Booth FW. Myogenic regulatory factors during regeneration of skeletal muscle in young, adult, and old rats. J Appl Physiol 1997, 83:1270-1275.
15. Jejurikar SS, Kuzon WM. Satellite cell depletion in degenerative skeletal muscle. Apoptosis 2003, 8:573-578.
16. Sveen ML, Schwartz M, Vissing J. High prevalence and phenotype-genotype correlations of limb girdle muscular dystrophy type 2I in Denmark. Ann Neurol 2006, 59:808-815. 10.1002/ana.20824, 16634037.
17. Fanin M, Nascimbeni AC, Fulizio L, Trevisan CP, Meznaric-Petrusa M, Angelini C. Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression. Am J Pathol 2003, 163:1929-1936. 10.1016/S0002-9440(10)63551-1, 1892408, 14578192.
18. Ponten E, Friden J. Immobilization of the rabbit tibialis anterior muscle in a lengthened position causes addition of sarcomeres in series and extra-cellular matrix proliferation. J Biomech 2008, 41:1801-1804. 10.1016/j.jbiomech.2008.03.006, 18460410.
19. Cohn RD, Henry MD, Michele DE, Barresi R, Saito F, Moore SA, Flanagan JD, Skwarchuk MW, Robbins ME, Mendell JR, et al. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell 2002, 110:639-648. 10.1016/S0092-8674(02)00907-8, 12230980.
20. Helliwell TR, Man NT, Morris GE, Davies KE. The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibres in dystrophies and inflammatory myopathies. Neuromuscul Disord 1992, 2:177-184. 10.1016/0960-8966(92)90004-P, 1483043.
21. Hodges BL, Hayashi YK, Nonaka I, Wang W, Arahata K, Kaufman SJ. Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies. J Cell Sci 1997, 110:2873-2881.
22. Blake DJ, Tinsley JM, Davies KE. Utrophin: a structural and functional comparison to dystrophin. Brain Pathol 1996, 6:37-47. 10.1111/j.1750-3639.1996.tb00781.x, 8866746.
23. Nguyen TM, Ellis JM, Love DR, Davies KE, Gatter KC, Dickson G, Morris GE. Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. J Cell Biol 1991, 115:1695-1700. 10.1083/jcb.115.6.1695, 2289198, 1757469.
24. de Paula F, Vieira N, Starling A, Yamamoto LU, Lima B, de Cassia PR, Vainzof M, Nigro V, Zatz M. Asymptomatic carriers for homozygous novel mutations in the FKRP gene: the other end of the spectrum. Eur J Hum Genet 2003, 11:923-930. 10.1038/sj.ejhg.5201066, 14647208.
25. Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA, Ponting CP, Estournet B, Romero NB, Mercuri E, et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet 2001, 69:1198-1209. 10.1086/324412, 1235559, 11592034.
26. Schwartz M, Hertz JM, Sveen ML, Vissing J. LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype. Neurology 2005, 64:1635-1637. 10.1212/01.WNL.0000157654.59374.E5, 15883334.
27. Mercuri E, Brockington M, Straub V, Quijano-Roy S, Yuva Y, Herrmann R, Brown SC, Torelli S, Dubowitz V, Blake DJ, et al. Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann Neurol 2003, 53:537-542. 10.1002/ana.10559, 12666124.
28. Paulsen G, Egner IM, Drange M, Langberg H, Benestad HB, Fjeld JG, Hallen J, Raastad T. A COX-2 inhibitor reduces muscle soreness, but does not influence recovery and adaptation after eccentric exercise. Scand J Med Sci Sports 2010, 20:e195-e207. 10.1111/j.1600-0838.2009.00947.x, 19522751.
29. Dubowitz V, Sewry CA. Muscle Biopsy - A practical Approach 2007, 3.
30. Corbu A, Scaramozza A, Badiali-DeGiorgi L, Tarantino L, Papa V, Rinaldi R, D'Alessandro R, Zavatta M, Laus M, Lattanzi G, et al. Satellite cell characterization from aging human muscle. Neurol Res 2010, 32:63-72. 10.1179/174313209X385725, 20092696.
31. Fitzsimons RB, Hoh JF. Embryonic and foetal myosins in human skeletal muscle. The presence of foetal myosins in duchenne muscular dystrophy and infantile spinal muscular atrophy. J Neurol Sci 1981, 52:367-384. 10.1016/0022-510X(81)90018-6, 7310440.
32. Schiaffino S, Gorza L, Dones I, Cornelio F, Sartore S. Fetal myosin immunoreactivity in human dystrophic muscle. Muscle Nerve 1986, 9:51-58. 10.1002/mus.880090108, 3513005.
33. Winter A, Bornemann A. NCAM, vimentin and neonatal myosin heavy chain expression in human muscle diseases. Neuropathol Appl Neurobiol 1999, 25:417-424. 10.1046/j.1365-2990.1999.00178.x, 10564532.
34. Sartore S, Gorza L, Schiaffino S. Fetal myosin heavy chains in regenerating muscle. Nature 1982, 298:294-296. 10.1038/298294a0, 7045696.
35. Biral D, Scarpini E, Angelini C, Salviati G, Margreth A. Myosin heavy chain composition of muscle fibers in spinal muscular atrophy. Muscle Nerve 1989, 12:43-51. 10.1002/mus.880120109, 2664503.
36. Winter A, Bornemann A. NCAM, vimentin and neonatal myosin heavy chain expression in human muscle diseases. Neuropathol Appl Neurobiol 1999, 25:417-424. 10.1046/j.1365-2990.1999.00178.x, 10564532.
37. Schiaffino S, Gorza L, Dones I, Cornelio F, Sartore S. Fetal myosin immunoreactivity in human dystrophic muscle. Muscle Nerve 1986, 9:51-58. 10.1002/mus.880090108, 3513005.
38. Grounds MD, Garrett KL, Lai MC, Wright WE, Beilharz MW. Identification of skeletal muscle precursor cells in vivo by use of MyoD1 and myogenin probes. Cell Tissue Res 1992, 267:99-104. 10.1007/BF00318695, 1310442.
39. Marsh DR, Criswell DS, Carson JA, Booth FW. Myogenic regulatory factors during regeneration of skeletal muscle in young, adult, and old rats. J Appl Physiol 1997, 83:1270-1275.
40. Voisin V, Sebrie C, Matecki S, Yu H, Gillet B, Ramonatxo M, Israel M, De la PS. L-arginine improves dystrophic phenotype in mdx mice. Neurobiol Dis 2005, 20:123-130. 10.1016/j.nbd.2005.02.010, 16137573.